Year: 2026
Type: article
Abstract: Cis-abienol is a labdane-type diterpenoid compound that can be used as a valuable precursor for ambergris-like fragrance compounds and for flavoring agents in tobacco. Conventional supply is based on plant extraction, low yield and high land cost, seasonal variation. However, microbial cell factories have shown to be a promising alternative, but the limitation in precursors, particularly the common C5 isoprene units isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), must be overcome. In this review, the heterologous biosynthesis of cis-abienol in engineered Escherichia coli, by using three different upstream pathways for precursor supply, namely the native MEP pathway, the heterologous MVA pathway and the synthetic isopentenol utilization pathway (IUP), is discussed. IPP and DMAPP are elongated into FPP and GGPP, which are subsequently cyclized by SsTPS and AbCAS to form cis-abienol in the downstream diterpene-synthesis module. Across three engineering rounds, direct DMAPP supplementation proved infeasible at scale owing to substrate cost and poor membrane permeability; simultaneous operation of the native MEP and heterologous MVA pathways increased theoretical precursor supply but imposed a strong metabolic burden, reaching only approximately 220 mg/L under high-cell-density fermentation; and the two-step IUP salvage pathway relieved cofactor pressure and achieved the highest reported titre, approximately 311.8 mg/L in shake-flask culture and 1375.7 mg/L in 1.3-L fed-batch fermentation, albeit at the cost of externally supplied DMAOH. These results point to the key design principles of evaluating the precursor generating capacity and host physiological fitness and indicate that dynamic regulation and enzyme engineering are key for future industrial translation.
Source: Theoretical and Natural Science
Author: Yunkai Wang
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W7235632242
